Vioxx Lawyers Discuss Merck Settlement
In a post here on Nov. 9, I noted that Merck & Co., after long insisting it would never settle the
27,000 Vioxx cases filed against it, turned an about face and agreed to a global
settlement in which it will pay $4.85 billion to resolve the bulk of these
cases. Yesterday, J. Craig Williams and I had a conversation with two of the lawyers who were instrumental in bringing this about. You can hear that conversation in the latest episode of our legal-affairs podcast Lawyer2Lawyer.
Williams and I discuss the terms of the settlement and its implications with our guests:
We invited representatives of Merck and also of the Defense Research Institute to appear on the
program, but they declined.
Listen to or download the show from this
page. Subscribe to future episodes of Lawyer2Lawyer usings its RSS feed or
Posted by Robert J. Ambrogi on November 21, 2007 at 01:04 PM | Permalink
| Comments (2)